Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
EMA Decision P/0336/2024 Paediatric Investigation Plan for retatrutide
In research systems, scientists have evaluated 5-Amino-1MQ for associations with NAD+ availability and cellular energetics due to its interaction with NNMT
The molecule was developed by the Australian pharmaceutical company Metabolic Pharmaceuticals (in collaboration with Monash University) and advanced through Phase I safety trials and a Phase IIb obesity efficacy trial enrolling approximately 900 participants in total
Supplied as a white to off-white lyophilized powder, readily soluble in water
US$ 28.19
US$ 21.15
US$ 20.59
US$ 21.69
US$ 21.52
